fever 37.5 after 6/12 hours, irritability and nervousness day 1; fever 37.5 after 6/12 hours, irritability and nervousness day 1; fever 37.5 after 6/12 hours, irritability and nervousness day 1; this case was reported by a physician via regulatory authority and described the occurrence of fever in a 3-month-old male patient who received men b nvs (bexsero) (batch number abxb81da, expiry date unknown) for prophylaxis. co-suspect products included meningococcal b recom vaccine + aloh + omv pre-filled syringe device (meningococcal b vaccine pre-filled syringe device) injection syringe for prophylaxis. on 3rd august 2021, the patient received bexsero (intramuscular) .5 ml and meningococcal b vaccine pre-filled syringe device. on 3rd august 2021, less than a day after receiving bexsero and meningococcal b vaccine pre-filled syringe device, the patient experienced fever (serious criteria other: serious as per reporter), irritability (serious criteria other: serious as per reporter) and nervousness (serious criteria other: serious as per reporter). on 5th august 2021, the outcome of the fever, irritability and nervousness were recovered/resolved. it was unknown if the reporter considered the fever, irritability and nervousness to be related to bexsero and meningococcal b vaccine pre-filled syringe device. this report is made by without prejudice and does not imply any admission or liability for the incident or its consequences. additional details were reported as follows: on 3rd august 2021, the patient's body temperature was 37.5 degrees celsius the duration of event fever, irritability and nervousness was reported as 2 days. initial information received from physician via regulatory authority on 28th february 2022: fever 37.5 after 6/12 hours, irritability and nervousness day 1

test date: 20210803; test name: body temperature; result unstructured data: (test result:37.5,unit:degree c,normal low:,normal high:)

na

na